Digital twins and Bayesian dynamic borrowing: Two recent approaches for incorporating historical control data

Author:

Burman Carl‐Fredrik12ORCID,Hermansson Erik1,Bock David1,Franzén Stefan3,Svensson David1

Affiliation:

1. Early Biometrics & Statistical Innovation, Data Science & Artificial Intelligence, R&D AstraZeneca Gothenburg Sweden

2. Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm Sweden

3. BMP Evidence Statistics, BioPharmaceuticals Medical AstraZeneca Gothenburg Sweden

Abstract

AbstractRecent years have seen an increasing interest in incorporating external control data for designing and evaluating randomized clinical trials (RCT). This may decrease costs and shorten inclusion times by reducing sample sizes. For small populations, with limited recruitment, this can be especially important. Bayesian dynamic borrowing (BDB) has been a popular choice as it claims to protect against potential prior data conflict. Digital twins (DT) has recently been proposed as another method to utilize historical data. DT, also known as PROCOVA™, is based on constructing a prognostic score from historical control data, typically using machine learning. This score is included in a pre‐specified ANCOVA as the primary analysis of the RCT. The promise of this idea is power increase while guaranteeing strong type 1 error control. In this paper, we apply analytic derivations and simulations to analyze and discuss examples of these two approaches. We conclude that BDB and DT, although similar in scope, have fundamental differences which need be considered in the specific application. The inflation of the type 1 error is a serious issue for BDB, while more evidence is needed of a tangible value of DT for real RCTs.

Publisher

Wiley

Reference52 articles.

1. Borrowing From Historical Control Data in Cancer Drug Development: A Cautionary Tale and Practical Guidelines

2. US Food and Drug Administration (FDA).Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials.2010.

3. European Medicines Agency (EMA).Qualification opinion for Prognostic Covariate Adjustment (PROCOVA™).2022.

4. The combination of randomized and historical controls in clinical trials;Pocock S;J Chronic Dis,1976

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3